| Antipsychotic drugs and tardive dyskinesia: preliminary results in an adolescent psychiatric ward. | |
| | |
MedLine Citation:
|
PMID: 7650076 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The systematic study of antipsychotic-induced movement disorders in young psychiatric patients is very sparse. We assessed the presence of tardive dyskinesia in an adolescent in-patient psychiatric ward. Eighteen per cent (3/17) exhibited either pronounced or subtle signs of tardive dyskinesia. Our study suggests that young psychiatric patients may develop signs of tardive dyskinesia even though they are exposed to relatively short-term neuroleptic treatment and at dosages that are relatively low. We advocate frequent and systematic monitoring of adolescent patients taking antipsychotic drugs in order to minimize the emergence of this long-term, troublesome complication of neuroleptic drugs. |
| | |
Authors:
|
A Dorevitch; I Meretyk; Y Umansky; E Galili-Weisstub |
Related Documents
:
|
2925466 - Electrodermally differentiated subgroups of anxiety patients and controls. ii: relation... 564176 - The management of vaginismus. 3722696 - Countertransference evolution in theory and practice. 2030196 - Predictors of differential response to cognitive, experiential, and self-directed psych... 55986 - Immunoglobulin e in renal disease. 18431816 - Meg recordings of patients with cns disorders before and after external magnetic stimul... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of clinical pharmacy and therapeutics Volume: 20 ISSN: 0269-4727 ISO Abbreviation: J Clin Pharm Ther Publication Date: 1995 Apr |
Date Detail:
|
Created Date: 1995-09-26 Completed Date: 1995-09-26 Revised Date: 2008-05-28 |
Medline Journal Info:
|
Nlm Unique ID: 8704308 Medline TA: J Clin Pharm Ther Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 63-5 Citation Subset: IM |
Affiliation:
|
Talbieh Mental Health Center, Jerusalem, Israel. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Antiparkinson Agents / adverse effects, therapeutic use Antipsychotic Agents / administration & dosage, adverse effects*, therapeutic use Dose-Response Relationship, Drug Drug Monitoring Drug Synergism Dyskinesia, Drug-Induced / etiology* Female Humans Male Sex Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antiparkinson Agents; 0/Antipsychotic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Monitoring plasma levels of fluphenazine during chronic therapy with fluphenazine decanoate.
Next Document: Prospective evaluation of ten methods for estimating creatinine clearance in children with varying d...